Aquestive Therapeutics Newsroom

Leerink Partners Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $12

Moomoo NewsOct 9 23:31 ET

Aquestive Therapeutics: A Buy Rating on Revolutionary Allergy Treatments and Strategic Pipeline Expansion

TipRanksOct 9 22:47 ET

Aquestive Therapeutics Analyst Ratings

BenzingaOct 8 14:08 ET

JMP Securities Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $9

Moomoo NewsOct 8 00:31 ET

Analysts Offer Insights on Healthcare Companies: Acadia Healthcare (ACHC), Aquestive Therapeutics (AQST) and Inspire Medical Systems (INSP)

TipRanksOct 1 01:34 ET

Lake Street Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $7

Moomoo NewsSep 30 09:33 ET

Leerink Partners Reiterates Outperform on Aquestive Therapeutics, Raises Price Target to $12

BenzingaSep 30 08:09 ET

Aquestive Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow JonesSep 30 08:06 ET

Aquestive Therapeutics Analyst Ratings

BenzingaSep 30 07:55 ET

H.C. Wainwright Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Raises Target Price to $10

Moomoo NewsSep 30 06:31 ET

JMP Securities Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $9

Moomoo NewsSep 30 00:32 ET

Aquestive Therapeutics: A Buy Rating on Underappreciated Market Potential and Innovative Pipeline

TipRanksSep 13 01:59 ET

Aquestive Therapeutics Analyst Ratings

BenzingaAug 14 06:54 ET

Buy Rating Affirmed for Aquestive Therapeutics as Anaphylm Poised to Transform Epinephrine Market

TipRanksAug 14 06:44 ET

H.C. Wainwright Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $9

Moomoo NewsAug 14 06:34 ET

Aquestive Therapeutics Analyst Ratings

BenzingaAug 12 10:07 ET

Analysts Offer Insights on Healthcare Companies: Kura Oncology (KURA) and Aquestive Therapeutics (AQST)

TipRanksAug 12 00:33 ET

Oppenheimer Keeps Their Buy Rating on Aquestive Therapeutics (AQST)

TipRanksAug 8 09:34 ET

Analysts Conflicted on These Healthcare Names: Aquestive Therapeutics (AQST), Eli Lilly & Co (LLY) and Owens & Minor (OMI)

TipRanksJul 30 02:34 ET

Oppenheimer Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $13

Moomoo NewsJul 27 03:31 ET